Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Clinical trial NCT01109524 · COMPLETED

Trial details

NCT number: NCT01109524
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Carcinoma Cancer of the Lung Non-Small-Cell Lung Carcinoma

Start date: 2010-07-01
Primary completion: 2012-09-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.